WHO ICTRP trial
Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination…
EUCTR2009-015758-39-GR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-015758-39-GR |
|---|---|
| Public title | Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination with Cisplatin, Fluourouracil and Docetaxel (DCF) in Locally Advanced or Metastatic Cancer of the Stomach and Gastro-oesophageal junction. - N/A |
| Scientific title | Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination with Cisplatin, Fluourouracil and Docetaxel (DCF) in Locally Advanced or Metastatic Cancer of the Stomach and Gastro-oesophageal junction. - N/A |
| Primary sponsor | Hellenic Oncology Research Group (HORG) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Greece |
| Conditions | This is a phase I/II study in order to evaluate the effect of adding panitumumab to an active regimen such as DCF in the treatment of chemotherapy - naive patients with advanced cancer of the stomach. |
| Interventions | Product Name: Panitumumab Product Code: - Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Panitumumab Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 20- |
| Registration date | Apr 10, 2010 |
| Secondary IDs | CT/09.10 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: